Carlson Capital »

Cidara Therapeutics shares owned by Carlson Capital

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Carlson Capital from 13F filings

Historical chart of Carlson Capital investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Carlson Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Carlson Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.5M 7.0k 220.89

More positions owned by Carlson Capital

Swk Hldgs Corp Com New (SWKH)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Affirm Hldgs Com Cl A Put Option (AFRM)
Carvana Cl A Put Option (CVNA)
Cyberark Software SHS (CYBR)
Synovus Finl Corp Com New (SNV)
Frontier Communications Pare
Electronic Arts (EA)
Sofi Technologies Put Option (SOFI)
Sealed Air (SEE)
EXACT Sciences Corporation (EXAS)
Avidity Biosciences Ord (RNA)
Huntington Bancshares Incorporated (HBAN)
Cullen/Frost Bankers (CFR)
Norfolk Southern (NSC)

View all positions for Carlson Capital

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BlackRock
BVF
UBS Group
Darwin Global Management
Vivo Capital
State Street Corporation
Susquehanna International
FMR
Leucadia National Corporation
Paradigm Biocapital Advisors
Citadel Advisors
Henderson Group
Glazer Capital

View all funds holding Cidara Therapeutics